1 – 28 of 28
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Deciphering the genetics and mechanisms of predisposition to multiple myeloma
(
- Contribution to journal › Article
- 2020
-
Mark
Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels
(
- Contribution to journal › Letter
-
Mark
Search for multiple myeloma risk factors using Mendelian randomization
(
- Contribution to journal › Article
-
Mark
International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM)
(
- Contribution to journal › Article
- 2019
-
Mark
Genome-wide interaction and pathway-based identification of key regulators in multiple myeloma
(
- Contribution to journal › Article
-
Mark
Transcriptome-wide association study of multiple myeloma identifies candidate susceptibility genes
(
- Contribution to journal › Article
- 2018
-
Mark
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression
(
- Contribution to journal › Article
-
Mark
Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma - an IMWG Research Project
(
- Contribution to journal › Article
-
Mark
Genetic correlation between multiple myeloma and chronic lymphocytic leukaemia provides evidence for shared aetiology
(
- Contribution to journal › Article
- 2017
-
Mark
Low expression of hexokinase-2 is associated with false-negative FDG–positron emission tomography in multiple myeloma
(
- Contribution to journal › Article
-
Mark
Genetic Predisposition to Multiple Myeloma at 5q15 Is Mediated by an ELL2 Enhancer Polymorphism
(
- Contribution to journal › Article
-
Mark
Genome-wide association study of clinical parameters in immunoglobulin light chain amyloidosis in three patient cohorts
(
- Contribution to journal › Letter
-
Mark
Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci
(
- Contribution to journal › Article
- 2016
-
Mark
Multiple myeloma risk variant at 7p15.3 creates an IRF4-binding site and interferes with CDCA7L expression
(
- Contribution to journal › Article
-
Mark
Genome-wide association study identifies variation at 6q25.1 associated with survival in multiple myeloma.
(
- Contribution to journal › Article
-
Mark
Safety and efficacy of pomalidomide plus low-dose dexamethasone in STRATUS (MM-010) : A phase 3b study in refractory multiple myeloma
(
- Contribution to journal › Article
-
Mark
Genome-wide association study identifies multiple susceptibility loci for multiple myeloma
(
- Contribution to journal › Article
- 2015
-
Mark
Profound impact of sample processing delay on gene expression of multiple myeloma plasma cells.
(
- Contribution to journal › Article
-
Mark
The 7p15.3 (rs4487645) association for multiple myeloma shows strong allele-specific regulation of the MYC-interacting gene CDCA7L in malignant plasma cells
(
- Contribution to journal › Letter
-
Mark
Cardiometabolic effects of genetic upregulation of the interleukin 1 receptor antagonist: a Mendelian randomisation analysis
(
- Contribution to journal › Article
- 2014
-
Mark
Inherited genetic susceptibility to monoclonal gammopathy of unknown significance
(
- Contribution to journal › Article
- 2013
-
Mark
International Myeloma Working Group Recommendations for the Treatment of Multiple Myeloma-Related Bone Disease.
(
- Contribution to journal › Article
-
Mark
The CCND1 c.870G > A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma
(
- Contribution to journal › Article
-
Mark
Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk
(
- Contribution to journal › Article
- 2012
-
Mark
MyelomA Genetics International Consortium
(
- Contribution to journal › Scientific review
-
Mark
Common variation at 3p22.1 and 7p15.3 influences multiple myeloma risk
(
- Contribution to journal › Article
- 2010
-
Mark
Chlamydia trachomatis antigens in enteroendocrine cells and macrophages of the small bowel in patients with severe irritable bowel syndrome
(
- Contribution to journal › Article
- 2005
-
Mark
International Staging System for Multiple Myeloma.
(
- Contribution to journal › Article